Clinical trial · Interventional
Ultraspound-guided Intralesional Injection of Cystic Hygroma - A Case Report
Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report
NCT07246928CI-TRIAL-00109931US: UltrasoundcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cystic Hygroma (Macro-cystic Lymphatic Malformation) | — | UNRESOLVED | — |
| Intralesional Injection of Cystic Hygroma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intralesional Injection of Bleomycin | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- pediatric patient
- interventionNames
- Procedure: Intralesional Injection of Bleomycin
Primary outcomes (2)
- measure
- improvement: change in lesion size
- timeFrame
- one year
- description
- reduction in lesion size
- measure
- improvement: reduction of lesion size
- timeFrame
- one year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Month
- Maximum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: Pediatric patients of age up to 12 years having cystic hygromas (macrocystic lymphatic malformations), from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital). -
References
Publications (0)
Data not yet available
No reference posted for this study.